Journal of Medical Humanities

, Volume 24, Issue 1–2, pp 79–103 | Cite as

Selling Sanity Through Gender: The Psychodynamics of Psychotropic Advertising

Abstract

This paper provides a brief visual history of the ways women patients, and specifically women patients whose marital status is identified in conjunction with their “illness,” have been constructed as abnormal in the images of advertisements designed to promote psychotropic medications to an audience of psychiatrists. The advertisements I discuss come from the two largest circulation American psychiatric journals, The American Journal of Psychiatry and Archives of General Psychiatry, between the years 1964 and 2001. I use the ads to focus on two concomitant narratives. On one hand, I show how the advertisements situate the rise of “wonder drugs” in the context of an era described as the “golden age of psychopharmacology,” during which time drug treatments helped revolutionize the diagnosis and treatment of anxiety, depression, and other outpatient mental illnesses in the United States. On the other hand, the advertisements also illustrate the ways in which these new scientific treatments could not function free of the culture in which they were given meaning. In the space between drug and wonder drug, or between medication and metaphor, the images thus hint at the ways psychotropic treatments became imbricated with the same gendered assumptions at play in an American popular culture intimately concerned with connecting “normal” and “heteronormal” when it came to defining the role of women in “civilization.”

pharmaceutical advertising gender biological psychiatry psychopharmaceuticals psychoanalysis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alexander, F., & Selesnick, S. (1966). The history of psychiatry. New York: Harper.Google Scholar
  2. Altschule, (1953). Body physiology in mental and emotional disorders. New York: Grune.Google Scholar
  3. Ayd, F. (1991). The early history of modern psychopharmacology. Neuropsychopharmacology, 5(2), 71–84.PubMedGoogle Scholar
  4. Balter, M. et al. (1974). Cross-national study of the extent of anti-anxiety/sedative drug use. New England Journal of Medicine, 290, 769–774.PubMedGoogle Scholar
  5. Cant, G. (1976, Feb. 1). Valiumania. New York Times Magazine, 34–54.Google Scholar
  6. Chambers, C. (1972). An assessment of drug use in the general population. In J. Sussman (Ed.), Drug use and social policy (pp. 50–61). New York: AMS Press.Google Scholar
  7. Cooley, D. (1956, January). The new nerve pills and your health. Cosmopolitan, p. 70.Google Scholar
  8. Friedan, B. (1963). The feminine mystique. New York: W. W. Norton.Google Scholar
  9. Corrodi, H. et al. (1967). The effect of some psychoactive drugs on central monoamine neurons. European Journal of Pharmacology, 1, 363–368.CrossRefPubMedGoogle Scholar
  10. Courtney, A., & Whipple, T. (1983). Sex stereotype in advertising. Massachussetts: Lexington Books.Google Scholar
  11. Douglas, S. (1994). Where the girls are: Growing up female with the mass media. New York: Times Books.Google Scholar
  12. Garb, T. (1993). Gender and representation. In F. Frascina (Ed.), Modernity and modernism: French painting in the nineteenth century (pp. 219–290). New Haven: Yale University Press.Google Scholar
  13. Goffman, E. (1979). Gender advertisements. London: Macmillan Press.Google Scholar
  14. Hawkins, J.W., & Aber, C. S. (1988). The content of advertisements in medical journals: Distorting the image of woman. Women and Health, 14(2), 45.Google Scholar
  15. Hayle, N. G. Jr. (1995). The rise and crisis of psychoanalysis in the United States: Freud and the Americans, 1917–1985. New YorkGoogle Scholar
  16. Healey, D. (1997). The antidepressant era. Cambridge: Harvard University Press.Google Scholar
  17. Johnson, J. (1973). Lesbian nation: The feminist solution. New York: Simon and Schuster.Google Scholar
  18. Josephson, S. (1996). From idolatry to advertising: Visual art and contemporary culture. New York: M.E. Sharpe.Google Scholar
  19. Koedt, A. (1971). Lesbianism and feminism. Notes from the third year: Women's liberation. New York: Radical Feminists.Google Scholar
  20. Kramer, P. (1994). Listening to Prozac. New York: Penguin.Google Scholar
  21. Levy, R. (1994). The role and value of pharmaceutical marketing. Archives of Family Medicine. 3, 327–332.CrossRefPubMedGoogle Scholar
  22. Listening to Eli Lilly. (1994, March 31). Wall Street Journal, B-1.Google Scholar
  23. Manheimer, D. et al. (1968). Psychotherapeutic drugs. California Medicine, 109, 445–451.PubMedGoogle Scholar
  24. Merriam, E. (1958, Nov. 8). The matriarchal myth, or The case of the vanishing male. The Nation, 331–5.Google Scholar
  25. Mulvey, L (1981). Afterthoughts...Inspired by “Duel in the Sun.” Framework, 15–17, 12–15.Google Scholar
  26. Nathanson, C. (1980). Social roles and health status among women: The significance of employment. Social Science and Medicine, 16, 1781–1789.Google Scholar
  27. Parry H., et al. (1973). National patterns of psychotherapeutic drug use. Archives of General Psychiatry, 28, 769–738.Google Scholar
  28. Parry, H. (1968). Use of psychotropic drugs by U.S. adults. Public Health Reports, 83, 799–810.PubMedGoogle Scholar
  29. Special report: Women in revolt. (1970, Mar. 23). Newsweek, 70.Google Scholar
  30. Propp, V. (1968). Morphology of the folktale. Austin: University of Texas Press.Google Scholar
  31. The American male: Why do women dominate him. (1959, March). Look, 40–45.Google Scholar
  32. The new feminists: Revolt against sexism. (1969, Nov. 21). Time, 53–56.Google Scholar
  33. The personality pill. (1993, Oct. 1). Time, 53.Google Scholar
  34. The promise of prozac. (1990, Mar. 26). Newsweek, 39.Google Scholar
  35. The politics of sex: Kate Millet of women's lib. (1977, Aug. 31). Newsweek, 31.Google Scholar
  36. Schlessinger, A. Jr. (1959, Jan.). The crisis in American masculinity. Esquire, 69–75.Google Scholar
  37. Smith, M.C. (1985). Small comfort: A history of the minor tranquilizers. New York: Praeger.Google Scholar
  38. Thompson, E. (1979). Sexual bias in drug advertisements. Social Science and Medicine, 13A, 187–191.Google Scholar
  39. Unsettling facts about the tranquilizers. (1958, Jan.). Consumer Reports, 4.Google Scholar
  40. Wallerstein, R.S. (1991). The future of psychotherapy. Bulletin of the Menninger Clinic, 55, 421–443.PubMedGoogle Scholar
  41. Wallis, C. (1989, Dec. 4). Onward women! Time, 81–89.Google Scholar
  42. Wong, D. T. et. al. (1974). A selective inhibitor of serotonin uptake. Life Sciences, 15, 471–79.CrossRefPubMedGoogle Scholar
  43. Wylie, P. (1955). Generation of vipers. 2nd ed. New York: Pocket Books.Google Scholar

Copyright information

© Human Sciences Press, Inc. 2003

Authors and Affiliations

  1. 1.FIPSE Medicine and Culture ProgramUniversity of MichiganAnn Arbor

Personalised recommendations